148 related articles for article (PubMed ID: 34503957)
1. Glucagonlike Peptide-1 Receptor Imaging in Individuals with Type 2 Diabetes.
Eriksson O; Velikyan I; Haack T; Bossart M; Laitinen I; Larsen PJ; Berglund JE; Antoni G; Johansson L; Pierrou S; Tillner J; Wagner M
J Nucl Med; 2022 May; 63(5):794-800. PubMed ID: 34503957
[TBL] [Abstract][Full Text] [Related]
2. Species differences in pancreatic binding of DO3A-VS-Cys
Eriksson O; Rosenström U; Selvaraju RK; Eriksson B; Velikyan I
Acta Diabetol; 2017 Nov; 54(11):1039-1045. PubMed ID: 28891030
[TBL] [Abstract][Full Text] [Related]
3. Receptor occupancy of dual glucagon-like peptide 1/glucagon receptor agonist SAR425899 in individuals with type 2 diabetes.
Eriksson O; Haack T; Hijazi Y; Teichert L; Tavernier V; Laitinen I; Berglund JE; Antoni G; Velikyan I; Johansson L; Pierrou S; Wagner M; Tillner J
Sci Rep; 2020 Oct; 10(1):16758. PubMed ID: 33028880
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Cu-64 and Ga-68 Radiolabeled Glucagon-Like Peptide-1 Receptor Agonists as PET Tracers for Pancreatic β cell Imaging.
Bandara N; Zheleznyak A; Cherukuri K; Griffith DA; Limberakis C; Tess DA; Jianqing C; Waterhouse R; Lapi SE
Mol Imaging Biol; 2016 Feb; 18(1):90-8. PubMed ID: 25987465
[TBL] [Abstract][Full Text] [Related]
5. In vivo imaging of the glucagonlike peptide 1 receptor in the pancreas with 68Ga-labeled DO3A-exendin-4.
Selvaraju RK; Velikyan I; Johansson L; Wu Z; Todorov I; Shively J; Kandeel F; Korsgren O; Eriksson O
J Nucl Med; 2013 Aug; 54(8):1458-63. PubMed ID: 23761918
[TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography imaging of the glucagon-like peptide-1 receptor in healthy and streptozotocin-induced diabetic pigs.
Nalin L; Selvaraju RK; Velikyan I; Berglund M; Andréasson S; Wikstrand A; Rydén A; Lubberink M; Kandeel F; Nyman G; Korsgren O; Eriksson O; Jensen-Waern M
Eur J Nucl Med Mol Imaging; 2014 Sep; 41(9):1800-10. PubMed ID: 24643781
[TBL] [Abstract][Full Text] [Related]
7. Pre-clinical evaluation of [(68)Ga]Ga-DO3A-VS-Cys(40)-Exendin-4 for imaging of insulinoma.
Selvaraju RK; Velikyan I; Asplund V; Johansson L; Wu Z; Todorov I; Shively J; Kandeel F; Eriksson B; Korsgren O; Eriksson O
Nucl Med Biol; 2014 Jul; 41(6):471-6. PubMed ID: 24857864
[TBL] [Abstract][Full Text] [Related]
8. Introduction of a fatty acid chain modification to prolong circulatory half-life of a radioligand towards glucose-dependent insulinotropic polypeptide receptor.
Khalil A; Hakhverdyan S; Cheung P; Bossart M; Wagner M; Eriksson O; Velikyan I
Nucl Med Biol; 2024; 128-129():108876. PubMed ID: 38241936
[TBL] [Abstract][Full Text] [Related]
9. [
Zhang P; Zhao Z; Zhang L; Wu W; Xu Y; Pan D; Wang F; Yang M
Nucl Med Biol; 2019; 74-75():19-24. PubMed ID: 31450071
[TBL] [Abstract][Full Text] [Related]
10. Protocol for Clinical GLP-1 Receptor PET/CT Imaging with [
Tokgöz S; Boss M; Prasad S; Shah P; Laverman P; van Riel M; Gotthardt M
Methods Mol Biol; 2023; 2592():143-153. PubMed ID: 36507990
[TBL] [Abstract][Full Text] [Related]
11. Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT.
Wild D; Wicki A; Mansi R; Béhé M; Keil B; Bernhardt P; Christofori G; Ell PJ; Mäcke HR
J Nucl Med; 2010 Jul; 51(7):1059-67. PubMed ID: 20595511
[TBL] [Abstract][Full Text] [Related]
12. Preliminary evaluation of 18F‑AlF‑NOTA‑MAL‑Cys40‑Exendin‑4 in rodent heart after myocardial ischemia and reperfusion.
Pan X; Xu Q; Chen J; Wang T; Zhang M; Wang H; Gao H
Mol Med Rep; 2019 Sep; 20(3):2276-2284. PubMed ID: 31257516
[TBL] [Abstract][Full Text] [Related]
13. Imaging of the Glucagon Receptor in Subjects with Type 2 Diabetes.
Eriksson O; Velikyan I; Haack T; Bossart M; Laitinen I; Larsen PJ; Berglund JE; Antoni G; Johansson L; Pierrou S; Tillner J; Wagner M
J Nucl Med; 2021 Jun; 62(6):833-838. PubMed ID: 33097629
[TBL] [Abstract][Full Text] [Related]
14. First-in-Human Evaluation of Positron Emission Tomography/Computed Tomography With [
Fujimoto H; Fujita N; Hamamatsu K; Murakami T; Nakamoto Y; Saga T; Ishimori T; Shimizu Y; Watanabe H; Sano K; Harada N; Nakamura H; Toyoda K; Kimura H; Nakagawa S; Hirai M; Murakami A; Ono M; Togashi K; Saji H; Inagaki N
Front Endocrinol (Lausanne); 2021; 12():717101. PubMed ID: 34489868
[TBL] [Abstract][Full Text] [Related]
15. Glucagon‑like peptide‑1 analogue exendin‑4 modulates serotonin transporter expression in intestinal epithelial cells.
Cui X; Zhao X; Wang Y; Yang Y; Zhang H
Mol Med Rep; 2020 Apr; 21(4):1934-1940. PubMed ID: 32319618
[TBL] [Abstract][Full Text] [Related]
16.
Li L; Zhao R; Hong H; Li G; Zhang Y; Luo Y; Zha Z; Zhu J; Qiao J; Zhu L; Kung HF
Nucl Med Biol; 2021; 102-103():87-96. PubMed ID: 34695640
[TBL] [Abstract][Full Text] [Related]
17. Assessment of glucagon receptor occupancy by Positron Emission Tomography in non-human primates.
Eriksson O; Velikyan I; Haack T; Bossart M; Evers A; Laitinen I; Larsen PJ; Plettenburg O; Takano A; Halldin C; Antoni G; Johansson L; Pierrou S; Wagner M
Sci Rep; 2019 Oct; 9(1):14960. PubMed ID: 31628379
[TBL] [Abstract][Full Text] [Related]
18. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
19. Glucagon-Like Peptide-1 Receptor PET/CT with 68Ga-NOTA-Exendin-4 for Detecting Localized Insulinoma: A Prospective Cohort Study.
Luo Y; Pan Q; Yao S; Yu M; Wu W; Xue H; Kiesewetter DO; Zhu Z; Li F; Zhao Y; Chen X
J Nucl Med; 2016 May; 57(5):715-20. PubMed ID: 26795291
[TBL] [Abstract][Full Text] [Related]
20. 68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET.
Brom M; Oyen WJ; Joosten L; Gotthardt M; Boerman OC
Eur J Nucl Med Mol Imaging; 2010 Jul; 37(7):1345-55. PubMed ID: 20111963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]